CJC1295 + DAC – 2mg (10 vials)

CJC-1295 with DAC – 2mg – 10 Vials

Product Overview

CJC-1295 with DAC is a synthetic peptide designed to act on growth hormone-releasing hormone (GHRH) receptors. The addition of a Drug Affinity Complex (DAC) is intended to extend its circulation time compared with shorter-acting peptide forms.

It has been investigated in research involving growth hormone regulation and related endocrine pathways. However, research findings should not be interpreted as proof of safety or effectiveness for general human use.

Product Details

• Product Name: CJC-1295 with DAC
• Listed Strength: 2mg
• Package Quantity: 10 vials
• Product Category: Synthetic Peptide
• DAC Component: Drug Affinity Complex
• Research Area: GHRH receptor activity and growth hormone regulation
• Manufacturer: Confirm with supplier
• Formulation: Confirm with supplier
• Storage Requirements: Follow verified manufacturer documentation

Scientific Background

CJC-1295 with DAC has been studied for its interaction with GHRH receptors, which are involved in regulating growth hormone release from the pituitary gland.

The DAC modification is intended to increase the peptide’s duration of circulation. This distinguishes it from shorter-acting CJC-1295 formulations that do not contain DAC.

Product Verification

Before listing or distributing this product, confirm:

• Whether 2mg refers to each vial or the entire package
• That the product contains the DAC-modified form, not a non-DAC variant
• Manufacturer identity and product labeling
• Batch identification and available quality documentation
• Storage and handling requirements
• Applicable regulatory status and distribution requirements

Important Safety and Regulatory Information

CJC-1295 with DAC is an investigational peptide and should not be presented as an approved treatment or as proven safe and effective for human use. Its safety profile and long-term effects are not sufficiently established for general therapeutic use.

This description is for product identification and research information only. It is not medical advice, a dosing guide, or a recommendation for human administration. Verify the product’s identity and regulatory status before publication.